N-[2-(azetidin-1-yl)-4-pyridinyl]-5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-1H-indazole-3-carboxamide
C25H23N7O2 — CID 118381679
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(azetidin-1-yl)-4-pyridinyl]-5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-1H-indazole-3-carboxamide
N-[2-(azetidin-1-yl)-4-pyridinyl]-5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-1H-indazole-3-carboxamide (PubChem CID 118381679) has the molecular formula C25H23N7O2 and a molecular weight of 453.51 g/mol. Its IUPAC name is N-[2-(azetidin-1-yl)-4-pyridinyl]-5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-1H-indazole-3-carboxamide.
Molecular Properties
| Compound Name | N-[2-(azetidin-1-yl)-4-pyridinyl]-5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-1H-indazole-3-carboxamide |
|---|---|
| PubChem CID | 118381679 |
| Molecular Formula | C25H23N7O2 |
| Molecular Weight | 453.51 g/mol |
| Exact Mass | 453.19 |
| IUPAC Name | N-[2-(azetidin-1-yl)-4-pyridinyl]-5-[5-(cyclopropanecarbonylamino)-3-pyridinyl]-1H-indazole-3-carboxamide |
| SMILES | O=C(Nc1ccnc(N2CCC2)c1)c1n[nH]c2ccc(-c3cncc(NC(=O)C4CC4)c3)cc12 |
| InChI | InChI=1S/C25H23N7O2/c33-24(15-2-3-15)29-19-10-17(13-26-14-19)16-4-5-21-20(11-16)23(31-30-21)25(34)28-18-6-7-27-22(12-18)32-8-1-9-32/h4-7,10-15H,1-3,8-9H2,(H,29,33)(H,30,31)(H,27,28,34) |
| InChIKey | VLKSIOZQBZPJHW-UHFFFAOYSA-N |
| XLogP | 3.83 |
| TPSA | 115.90 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.51 |
| LogP ≤ 5 | 3.83 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118381679 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.